Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Lefranc

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
European Radiology|August 28, 2003
Intracranial tuberculoma: is diffusion-weighted imaging useful in the diagnosis?Niloufar Sadeghi, Sandrine Rorive, Florence Lefranc
Bulletin Du Cancer|April 9, 2008
[The sodium pump could constitute a new target to combat glioblastomas]Florence Lefranc, Tatjana Mijatovic, Robert Kiss
The Oncologist|January 1, 2008
Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomasFlorence Lefranc, Vincenzo Facchini, Robert Kiss
Seminars in Cancer Biology|June 13, 2017
Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological testsFlorence Lefranc, Nurhayat Tabanca, Robert Kiss
Clinical Neurosurgery|March 27, 2007
Surgery of intraspinal cord tumorsJacques Brotchi, Michael Bruneau, Florence Lefranc, et al.
Therapeutic Advances in Medical Oncology|July 7, 2018
Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectivesNuria Kotecki, Florence Lefranc, Daniel Devriendt, et al.
Current Medicinal Chemistry|April 10, 2009
Naphthalimides and azonafides as promising anti-cancer agentsLaurent Ingrassia, Florence Lefranc, Robert Kiss, et al.
International Journal of Oncology|April 6, 2006
Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)Florence Lefranc, Paul Yeaton, Jacques Brotchi, et al.
Glycobiology|July 15, 2006
Galectin-1: a small protein with major functionsIsabelle Camby, Marie Le Mercier, Florence Lefranc, et al.
Cancer Treatment Reviews|July 24, 2018
Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?Florence Lefranc, Emilie Le Rhun, Robert Kiss, et al.
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
European Radiology|August 28, 2003
Intracranial tuberculoma: is diffusion-weighted imaging useful in the diagnosis?Niloufar Sadeghi, Sandrine Rorive, Florence Lefranc
Bulletin Du Cancer|April 9, 2008
[The sodium pump could constitute a new target to combat glioblastomas]Florence Lefranc, Tatjana Mijatovic, Robert Kiss
The Oncologist|January 1, 2008
Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomasFlorence Lefranc, Vincenzo Facchini, Robert Kiss
Seminars in Cancer Biology|June 13, 2017
Assessing the anticancer effects associated with food products and/or nutraceuticals using in vitro and in vivo preclinical development-related pharmacological testsFlorence Lefranc, Nurhayat Tabanca, Robert Kiss
Clinical Neurosurgery|March 27, 2007
Surgery of intraspinal cord tumorsJacques Brotchi, Michael Bruneau, Florence Lefranc, et al.
Therapeutic Advances in Medical Oncology|July 7, 2018
Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectivesNuria Kotecki, Florence Lefranc, Daniel Devriendt, et al.
Current Medicinal Chemistry|April 10, 2009
Naphthalimides and azonafides as promising anti-cancer agentsLaurent Ingrassia, Florence Lefranc, Robert Kiss, et al.
International Journal of Oncology|April 6, 2006
Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)Florence Lefranc, Paul Yeaton, Jacques Brotchi, et al.
Glycobiology|July 15, 2006
Galectin-1: a small protein with major functionsIsabelle Camby, Marie Le Mercier, Florence Lefranc, et al.
Cancer Treatment Reviews|July 24, 2018
Glioblastoma quo vadis: Will migration and invasiveness reemerge as therapeutic targets?Florence Lefranc, Emilie Le Rhun, Robert Kiss, et al.
Pageof 14